Mid-Atlantic Bio

Please check back in the coming weeks for a finalized program complete with listings for speakers, panel sessions, and company presentations.

NOVEMBER 4 - 6, 2009

The Washington, D.C. Convention Center

801 Mount Vernon Place, NW
Washington, DC 20001
View Larger Map

WEDNESDAY – NOVEMBER 4, 2009

5:30 pm – 7:30 pm - Opening Reception
DC Coast, 1401 K St NW, Washington, DC 20005
* Open to all registered conference attendees

THURSDAY – NOVEMBER 5, 2009

8:00 am – 7:30 pm - Conference Registration Open, L Street Concourse

8:00 am – 9:00 am - Networking Continental Breakfast

9:00 am – 10:30 am - Opening Plenary Session

Healthcare Policy Panel
Health care experts and health policy insiders will discuss how health care reform will likely impact the bioscience industry in the coming years.

• Moderator: Steve Usdin, Senior Editor, BioCentury Publications, Inc.
• The Honorable Anna Eshoo (D-CA)
• The Honorable Charles Boustany (R-LA)
• Tony Zook, CEO of AstraZeneca North America, and President of MedImmune

10:30 am – 10:45 am - Refreshment Break

10:45 am – 12:15 pm - Panel Sessions

Biofuels – Innovative Biotechnology Meets Commercial Needs

• Moderator: Joel Stone, SVP Product & Business Development, Osage Bio Energy LLC
• Peter A. Nitze, EVP and COO, Martek Biosciences Corporation
• Douglas A. Durante, Executive Director, Clean Fuels Development Coalition (CFDC)
• Hans Foerster, Director of Marketing- Grain Processing Americas, Genencor International
• Matthew Carr, Director, Policy, Industrial & Environmental, BIO
• W. Steven Burke, President and CEO, Biofuels Center of North Carolina

If Venture Capital Is Broken, Why Are So Many People Still Doing It?

• Moderator: Brenda Gavin, Quaker BioVentures
• Lauren Silverman, Novartis Option Fund
• Martin Vogelbaum, Rho Ventures
• Tony Natale, Prism VentureWorks

10:45 am – 12:15 pm - Company Presentations

12:15 pm - 1:30 pm - Networking Lunch Buffet, Exhibit Hall, Limited seating

1:45 pm - 3:45 pm - Plenary Sessions

Tom Watkins, CEO, Human Genome Sciences

Followed by a panel on

Innovative Life Science Business Strategies in an Uncertain Environment

• Moderator: Barbara Kosacz, Partner, Cooley Godward Kronish LLP
• Michael Steiner, Ph.D., Partner, JSB-Partners
• Jessica Chutter, MBA, Managing Director, Morgan Stanley & Company, Inc.
• BJ Bormann, Senior Vice President at Boehringer Ingelheim Pharmaceuticals

3:45 pm – 4:00 pm - Refreshment Break

4:00 pm – 5:30 pm - Panel Sessions

Without a Net – CEOs Discuss How Their Companies Prosper, Even Today

• Moderator: Doug Doerfler, Preident and CEO, MaxCyte
• Steve Dubin, Chief Executive Officer, Martek Biosciences Corporation
• Rachel King, Chief Executive Officer, GlycoMimetics
• Mike Grisham, Chief Executive Officer, GPB Scientific, LLP
• David Kalergis, Chief Executive Officer, Diffusion Pharmaceuticals

Accelerating and Enhancing Drug Development

• Moderator: Stephen Horrigan, Ph.D., Vice President, Research and Development, PGxHealth, Clinical Data, Inc.
• David C. Stump, M.D., Executive Vice President of Research and Development, Human Genome Sciences Inc.
• David Christ, Ph.D., SNC Partners LLC
• Kenneth C. Carter, Ph.D., SVP, Strategic Partnerships, Avalon Group, Clinical Data, Inc.

4:00 pm – 5:30 pm - Company Presentations

5:30 pm – 7:30 pm - Mid-Atlantic Bio Reception, Exhibit Hall
* Open to all attendees

MID-ATLANTIC BIO RECEPTION:

Enjoy an evening alongside some of the most influential leaders in bioscience and have the opportunity to network and build relationships in a relaxed social atmosphere.

7:30 pm – 9:30 pm - CEO & Investor Reception, FOXKISER

* By invitation only.

FRIDAY – NOVEMBER 6, 2009

7:00 am – 2:00 pm - Conference Registration Open, L Street Concourse

7:00 am – 2:00 pm - Innovation Corridor Open

7:00 am – 8:30 am - Networking Continental Breakfast

8:30 am – 10:00 am - Panel Sessions

Biomarkers and Personalized Medicine: Challenges and Opportunities

• Moderator: Jeff Cossman, Chief Scientific Officer and President, United States Diagnostic Standards
• Scott Allocco, President, BioMarker Strategies
• Amy Miller, Policy Director, Personalized Medicine Coalition
• Dr. Mark Sobel, Executive Director, American Society for Investigative Pathology

Go Where the Money Is: An Insider’s Briefing on Accessing Federal Grants

• Moderator: Robert Brooke, Director, Federal Funding Programs, Center for Innovative Technology
• Greg Baxter, Ph.D., Program Director, National Science Foundation
• Lenka Fedorkova, Assistant Program Manager, SBIR & STTR Program, National Institutes of Health
• Dr. Ali Andalibi, Program Director, National Cancer Institute

8:30 am – 10:00 am - Company Presentations

10:00 am – 10:15 am - Refreshment Break

10:15 am – 11:00 am - Plenary Session

R.J. Kirk, CEO of Third Security and Intrexon

11:15 am – 12:30 am - Panel Sessions

The Crown Jewels of Biotech Value: New Developments and Strategies for Intellectual Property

• Moderator: Rob Capon. Senior Vice President, PGxHealth LLC
• Eva M. Jack, Managing Director, MedImmune Ventures, Inc.
• David Vance, Patent Counsel, PGXHealth LLC
• Esther Kepplinger, Director of Patent Operations, Wilson Sonsini Goodrich & Rosati
• Chris Jeffers, Of-Counsel, Wombyle Carlyle Sandridge & Rice, PLLC

How to Expedite Moving Submissions through the FDA in 2009

• James Kenimer, , Ph.D., Founder and CEO, Biologics Consulting Group
• Beth A. Burnside, Ph.D., Senior Vice Present, Regulatory Affairs, Compliance and Strategic Planning, Middlebrook Pharmaceuticals
• Robert Yetter, Associated Director, Review Management, National Institutes of Health
• Lee Barsky, Vice President, CRO Services, Accelovance

Vaccines:  Biotech’s Next “Big Thing”

• Moderator: Ray Cypess, CEO, ATCC
• Shawn Patrick O’Brien, President and CEO, Profectus Biosciences, Inc.
• David Ayares, Ph.D., CEO and Chief Scientific Officer, Revivicor, Inc.
• Brandon J. Price, Ph.D., CEO, Falcon Ridge Associates

11:15 am – 12:30 pm - Company Presentations

12:30 am – 2:00 pm - Closing Plenary Luncheon, Howard Dean